Patent details

EP2348048 Title: Antagonistic Anti-HTNFSF13B Human Antibodies

Basic Information

Publication number:
EP2348048
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101846756
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Antagonistic Anti-HTNFSF13B Human Antibodies
French Title of Invention:
Anticorps humain antagonist anti-HTNFSF13B
German Title of Invention:
Antagonistisch human anti-HTNFSF13B Antikörper
SPC Number:

Dates

Filing date:
15/08/2002
Grant date:
19/11/2014
EP Publication Date:
19/11/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/07/2011
EP B1 Publication Date:
19/11/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/08/2016
Expiration date:
15/08/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/08/2002
 
 

Name:
Eli Lilly and Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/12/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Gelfanova Valentina Pavlovna
Address:
United States (US)

2

Name:
Witcher Derrick Ryan
Address:
United States (US)

3

Name:
Rathnachalamm Radhakrishnam
Address:
United States (US)

4

Name:
Hale John Edward
Address:
United States (US)

5

Name:
Kikly Kristine Kay
Address:
United States (US)

Priority

Priority Number:
312808 P
Priority Date:
16/08/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
12/08/2015
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages